Volume 5, Issue 4, Page 1 (April 2009)
1 of 35
PREVIEW
FULL TEXT
FULL-TEXT PDF (203 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
DOWNLOAD IMAGES
NEED REPRINTS?
BOOKMARK ARTICLE
A test that diagnoses Alzheimer's disease using levels of amyloid-beta and tau protein in cerebrospinal fluid could be on the market within 2 or 3 years, according to Leslie M. Shaw, Ph.D.
PII: S1553-3212(09)70072-X
doi:10.1016/S1553-3212(09)70072-X
© 2009 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
PREVIEW